DNase1L3 alterations were identified in patients with familial SLE (118), characterized by early disease onset, a variable degree of renal involvement, positive ANA and anti-dsDNA, ANCA, and low complement fractions C3 and C4. This evidence concerns the gene DNASE1L3 and systemic lupus erythematosus.